News

10

Nov, 2020

Louise Hill Presents NeoVanc Sub-study Results at ESPID 2020

Tags: ,

Louise Hill presented the findings of a NeoVanc sub-study at ESPID’s 2020 Virtual Meeting in late October. Below is a summary of the study and findings. Enterococcus (a bacterium) and candida (a fungus) can sometimes be found on or in the human body.  Occasionally enterococci can develop resistance to one of the antibiotics usually used to treat it – vancomycin. Vancomycin use has been linked to a rise in vancomycin-resistant enterococci and candida on or in the bodies of babies admitted to the neonatal intensive care unit. Babies with vancomycin-resistant […]

READ MORE

16

Oct, 2020

c4c publishes first peer reviewed publication

Tags:

The c4c project, co-coordinated by Penta together with Janssen, Bayer and the University of Liverpool, has had its first review, titled “European research networks to facilitate drug research in children”, published by the British Journal of Clinical Pharmacology.  We are proud to have the Penta_ID Network involved in such an impactful project as a speciality network.   This review discusses the need for a structured approach to drug development by establishing and utilizing research networks and infrastructure. The publication explores how research networks and infrastructure can address the unmet medical […]

READ MORE

16

Oct, 2020

Penta Projects in Schools: What do young people know about HIV?

 

Authors: Elena Mozzo; Valentina Ortolan; Elena Badio; Federica Batterman; and Chiara Novello In October 2019, Penta began hosting HIV educational sessions in 5 high schools in Padova, Italy. From October to December 2019, a total of 13 meetings were held with 16-year-old students. For each session, the first 2 hours consisted of a medical doctor discussing the scientific aspects of HIV infection, followed by 2 hours with an HIV activist, discussing the social aspects of HIV. Each student who attended the session was asked to complete an anonymous questionnaire before […]

READ MORE

15

Oct, 2020

How European Paediatric emergency departments responded to the first wave of SARS-CoV-2 Pandemic

Tags: ,

Between February and May 2020, during the first wave of the COVID-19 pandemic, we sent out a survey to all European paediatric sites within the Penta ID research network. The aim of the study was to describe the implementation of SARS-CoV-2 disease (COVID-19) testing and infection control strategies, and their evolution in paediatric emergency departments in Europe. Although infection control strategies and even discharge of patients relied heavily on receiving SARS-CoV-2 test results, most hospitals only received these after considerable delay, often more than twenty-four hours. Shortening turnaround times for […]

READ MORE
NEWSLETTER

We would like to update you on our recent activities